1. Home
  2. LOAN vs RNXT Comparison

LOAN vs RNXT Comparison

Compare LOAN & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

N/A

Current Price

$4.00

Market Cap

47.6M

Sector

Real Estate

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

N/A

Current Price

$1.47

Market Cap

42.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LOAN
RNXT
Founded
1989
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.6M
42.4M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
LOAN
RNXT
Price
$4.00
$1.47
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
22.4K
526.4K
Earning Date
04-16-2026
05-14-2026
Dividend Yield
10.06%
N/A
EPS Growth
N/A
20.00
EPS
0.21
N/A
Revenue
$8,666,307.00
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
N/A
$279.78
P/E Ratio
$19.38
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$3.90
$0.70
52 Week High
$5.79
$1.56

Technical Indicators

Market Signals
Indicator
LOAN
RNXT
Relative Strength Index (RSI) 45.25 68.67
Support Level $4.03 $0.83
Resistance Level $4.26 $1.51
Average True Range (ATR) 0.07 0.15
MACD 0.00 0.02
Stochastic Oscillator 35.96 86.96

Price Performance

Historical Comparison
LOAN
RNXT

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: